The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia

Health Policy
Rachel J KnottPhilip M Clarke

Abstract

This paper assesses whether the concession card, which offers discounted out-of-pocket costs for prescription medicines in Australia, affects discontinuation and adherence to statin therapy. The analysis uses data from the Australian Hypertension and Absolute Risk Study (AusHEART), which involves patients aged 55 years and over who visited a GP between April and June 2008. Socioeconomic and clinical information was collected and linked to administrative data on pharmaceutical use. Patients without a concession card were 63% more likely (hazard ratio (HR) 95% confidence interval (CI): 1.14-2.33) to discontinue and 60% (odds ratio (OR) CI: 1.04-2.44) more likely to fail to adhere to therapy compared to concessional patients. Smokers were 2.12 (HR CI: 1.39-3.22) times more likely to discontinue use and 2.23 (OR CI: 1.35-3.71) times more likely to fail to adhere compared to non-smokers. Patients who had recently initiated statin medication were also 2.28 (HR CI: 1.22-4.28) times more likely to discontinue use. In conclusion, higher copayments act as a disincentive for persistent and adherent use of statin medication.

References

Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Jun 24, 2004·Journal of General Internal Medicine·Jeffrey J EllisA Mark Fendrick
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Jun 2, 2006·The New England Journal of Medicine·John HsuJoseph V Selby
Oct 24, 2008·Pharmacoepidemiology and Drug Safety·Anna HyndJames Semmens
Jan 1, 2008·Clinical Therapeutics·Arja Helin-SalmivaaraRisto Huupponen
Aug 30, 2011·Australian Health Review : a Publication of the Australian Hospital Association·Anna KempElizabeth E Roughead
Dec 13, 2012·The Medical Journal of Australia·Rachel J KnottPhilip M Clarke

❮ Previous
Next ❯

Citations

Dec 29, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·L P ThaiA I Vitry
Nov 26, 2015·Preventing Chronic Disease·Gibril J NjieUNKNOWN Community Preventive Services Task Force
Mar 3, 2017·Heart·Beatriz González López-ValcárcelGabriel Sanfélix-Gimeno
Sep 26, 2017·Current Medical Research and Opinion·Louise E BartlettElizabeth E Roughead
Jun 30, 2021·Journal of Managed Care & Specialty Pharmacy·Anna HungLeah L Zullig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Australian and New Zealand Journal of Public Health
Evan DoranDavid Henry
The American Journal of Managed Care
Teresa B GibsonShaohung Wang
The American Journal of Managed Care
Teresa B GibsonRon Z Goetzel
The Medical Journal of Australia
P McManusA Mant
© 2022 Meta ULC. All rights reserved